Telatinib
Cat. No.:YN440104
产品名称: | Telatinib |
CAS No.: | 332012-40-5 |
Chemical Name: | 4-[[[4-[(4-chlorophenyl)amino]furo[2,3-d]pyridazin-7-yl]oxy]methyl]-N-methyl-2-pyridinecarboxamide |
Synonyms: | Bay 57-9352 |
分子量: | 409.83 |
分子式: | C₂₀H₁₆ClN₅O₃ |
SMILES: | O=C(C1=NC=CC(COC2=NN=C(NC3=CC=C(Cl)C=C3)C4=C2OC=C4)=C1)NC |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | Telatinib是有口服活性的VEGFR2,VEGFR3,PDGFα和c-Kit的小分子抑制剂,IC50值分别为6,4,15,1 nM。 |
IC50和靶点: | [{name:"VEGFR2:6 nM (IC50)"},{name: "VEGFR3:4 nM (IC50)"},{name: "PDGFRα:15 nM (IC50)"},{name: "c-Kit:1 nM (IC50)"}] |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Steeghs, N., Gelderblom, H., Roodt, J.O., et al.Hypertension and rarefaction during treatment with telatinib, a small molecule angiogenesis inhibitorClin. Cancer Res.14(11),3470-3476(2008)
Sodani, K., Patel, A., Anreddy, N., et al.Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivoBiochem. Pharmacol.89(1),52-61(2014)